Treatment options for leishmaniasis

Area of Science:

• Parasitology
• Infectious Diseases
• Drug Discovery

Background:

• Leishmaniasis presents in cutaneous, mucocutaneous, and visceral forms, with visceral leishmaniasis being life-threatening.
• Current treatments for leishmaniasis face challenges including cost, toxicity, lengthy durations, and emerging drug resistance.
• The need for novel and improved therapeutic strategies for leishmaniasis is critical.

Purpose of the Study:

• To review conventional drugs used for leishmaniasis treatment.
• To discuss emerging treatment options, including immunotherapy and immunochemotherapy.
• To explore future prospects for leishmaniasis therapeutics.

Main Methods:

• Literature review of existing and novel leishmaniasis treatments.
• Analysis of conventional drug efficacy, limitations, and resistance patterns.
• Evaluation of immunotherapeutic and immunochemotherapeutic approaches.

Main Results:

• Conventional drugs for leishmaniasis vary in effectiveness, cost, and toxicity.
• Immunotherapy and immunochemotherapy represent promising avenues for leishmaniasis treatment.
• Drug resistance and treatment side effects necessitate the development of alternative strategies.

Conclusions:

• Leishmaniasis treatment requires a multifaceted approach, addressing drug resistance and toxicity.
• Novel therapies like immunotherapy offer potential for improved leishmaniasis outcomes.
• Continued research into new drugs and treatment modalities is essential for combating leishmaniasis effectively.